Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial

This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.

Detalles Bibliográficos
Autores principales: Zumsteg, Zachary S., Spratt, Daniel E., Daskivich, Timothy J., Tighiouart, Mourad, Luu, Michael, Rodgers, Joseph P., Sandler, Howard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489808/
https://www.ncbi.nlm.nih.gov/pubmed/32902647
http://dx.doi.org/10.1001/jamanetworkopen.2020.15083
_version_ 1783581933718994944
author Zumsteg, Zachary S.
Spratt, Daniel E.
Daskivich, Timothy J.
Tighiouart, Mourad
Luu, Michael
Rodgers, Joseph P.
Sandler, Howard M.
author_facet Zumsteg, Zachary S.
Spratt, Daniel E.
Daskivich, Timothy J.
Tighiouart, Mourad
Luu, Michael
Rodgers, Joseph P.
Sandler, Howard M.
author_sort Zumsteg, Zachary S.
collection PubMed
description This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.
format Online
Article
Text
id pubmed-7489808
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-74898082020-09-25 Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial Zumsteg, Zachary S. Spratt, Daniel E. Daskivich, Timothy J. Tighiouart, Mourad Luu, Michael Rodgers, Joseph P. Sandler, Howard M. JAMA Netw Open Research Letter This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer. American Medical Association 2020-09-09 /pmc/articles/PMC7489808/ /pubmed/32902647 http://dx.doi.org/10.1001/jamanetworkopen.2020.15083 Text en Copyright 2020 Zumsteg ZS et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Zumsteg, Zachary S.
Spratt, Daniel E.
Daskivich, Timothy J.
Tighiouart, Mourad
Luu, Michael
Rodgers, Joseph P.
Sandler, Howard M.
Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title_full Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title_fullStr Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title_full_unstemmed Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title_short Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
title_sort effect of androgen deprivation on long-term outcomes of intermediate-risk prostate cancer stratified as favorable or unfavorable: a secondary analysis of the rtog 9408 randomized clinical trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489808/
https://www.ncbi.nlm.nih.gov/pubmed/32902647
http://dx.doi.org/10.1001/jamanetworkopen.2020.15083
work_keys_str_mv AT zumstegzacharys effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT sprattdaniele effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT daskivichtimothyj effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT tighiouartmourad effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT luumichael effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT rodgersjosephp effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial
AT sandlerhowardm effectofandrogendeprivationonlongtermoutcomesofintermediateriskprostatecancerstratifiedasfavorableorunfavorableasecondaryanalysisofthertog9408randomizedclinicaltrial

Ejemplares similares